JR
Julio Rosenstock
Endocrinology, Diabetes & Metabolism
Credentials: · ·
History
Internal Medicine
Research
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
New England Journal of Medicine · 2016 · 5,096 citations
Once-Weekly Semaglutide in Adults with Overweight or Obesity
New England Journal of Medicine · 2021 · 3,798 citations
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
New England Journal of Medicine · 2021 · 1,567 citations
- MR
28 papers
- PR
27 papers
24 papers
23 papers
- WC
23 papers
20 papers
- LB
20 papers
- VA
20 papers
Clinical trials
- 2013
Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks
Principal investigator · Completed · Phase 2
Elcelyx Therapeutics, Inc.
- 2025–2027
Site PI · Not yet recruiting · Phase 3
Oramed, Ltd.